The transport of anionic species across phospholipid bilayers is an important biological function that plays a vital role in cellular and organismal homeostasis. The function is normally performed by transmembrane transport proteins, but several diseases have been linked to malfunctioning or malregulation of these proteins (so-called "channelopathies"). As a consequence, supramolecular chemists have tried to develop synthetic molecules that can transport anions across biological membranes. While the original goal of this endeavor was the development of potential therapeutics for channelopathies, it is now clear that there are several other potential medical and nonmedical applications for synthetic transmembrane anion transporters. The medical applications of synthetic anion transporters have been widely explored, especially their potential as anticancer agents. However, there are many other applications of synthetic anion transporters that are often overlooked. These range from antibacterial activity and drug delivery, to nonmedical applications such as biomimicry, the development of optical sensors, catalysis, organic synthesis and others. In this review, we aim to highlight the versatility of synthetic transmembrane anion transporters and to convince chemists to look beyond channelopathies and anticancer activity as applications of artificial anion transporters.
Simple 1,3-diphenylureas are capable of transporting carboxylic acid-based drugs across phospholipid bilayers without affecting the permeability of other physiological anions such as chloride.
There is a growing fear that bacteria are emerging that are resistant to most known antibiotics, which could lead to an increasing number of fatalities due to bacterial infections. There is therefore an urgent need for the development of novel antibacterial products, preferably with novel mode of actions for which there are no known resistance pathways. We have previously found serendipitously that a simple urea-based compound functions as a potent antibacterial agent. In this manuscript, we use bacterial cytological profiling (BCP) to determine its mechanism of action. BCP reveals that the urea is acting through a membrane-based pathway that is comparable to, but distinct from, the mechanism of cationophore calcimycin. Additional liposome-based assays suggest that the likely mechanism of action of this mono-urea is transmembrane anion transport. This finding highlights that synthetic anionophores could be used as potential antibiotics. Graphical abstract
Misregulation of transmembrane ion transport in biological systems has been linked to a variety of diseases. As a result, supramolecular chemists have been trying to develop small molecules that facilitate the transmembrane transport of several ionic species. However, ion transport by small molecules is a passive process and needs to be overall charge neutral (i.e., when an ion is transported across a membrane, another ion needs to be transported as well to avoid charge separation). Ion pair receptors could therefore have great potential as transmembrane ion transporters because they can facilitate transport of an overall neutral species. Furthermore, ditopic ion pair receptors also have the potential to transport biologically important zwitterionic species, such as amino acids. In this manuscript, we report the synthesis of a series of ditopic receptors based on squaramides as the anion binding unit and 18-crown-6 as the cation binding unit. UV-vis and NMR titrations revealed that these compounds can bind a variety of chloride salts, especially KCl. Furthermore, liquid–liquid extractions and transport experiments using bulk liquid membranes and liposomes indicate that these ditopic receptors are capable of transporting chloride salts and hydrophilic amino acids. In fact, compound 5 was even able to facilitate the transport of amino acids with charged side chains at physiological pH (arginine and glutamate), making it the first example of a small molecule that can transport these highly polar and charge-dense species. These findings open up the possibility of using these receptors in a wide range of biological applications.
The development of synthetic compounds capable of transporting chloride anions across biological membranes has become an intensive research field in the last two decades. Progress is driven by the desire to develop treatments for chloride transport related diseases (e.g., cystic fibrosis), cancer or bacterial infections. In this manuscript, we use high-throughput screening and machine learning to identify novel scaffolds, and to find the molecular features needed to achieve potent chloride transport that can be generalized across diverse chemotypes. 1894 compounds were tested, 59 of which had confirmed transmembrane chloride transport ability. A machine learning (ML) binary classification model indicated that MolLog P is the most important feature to predict transport ability, but it is not sufficient by itself. The best ML model was able to identify potential chloride transporters from the DrugBank database and the predictions were experimentally validated. These insights can provide other researchers with inspiration and guidelines to develop ever more potent chloride transporters.
Lipid bilayer membranes are essential cellular permeability barriers that strictly limit the passage of polar molecules and macromolecules, thereby compartmentalizing cellular biochemistry and limiting the accessible chemical space for therapeutics. Membrane-traversing peptides (MTPs) are a diverse group of peptides defined by the ability to traverse synthetic or cellular membranes without causing permeabilization and without the assistance of specific transport proteins. These peptides fundamentally defy classical thermodynamic models of membrane permeability as they can cross lipid bilayers and deliver large polar cargoes, including peptides and proteins, into cells, despite having high net charge and low hydrophobicity. In this review, we challenge the idea of single, discrete mechanisms to describe how peptides traverse membranes and define a broad mechanistic landscape shaped by the conserved properties of MTPs and the unique physical chemistry and polymorphic phase behavior of lipid bilayers. We describe experimental assays and model systems that can be used to study MTP translocation and cargo delivery in synthetic systems and living cells. We use information obtained from comprehensive databases to consider the shared physical chemical space of MTPs. We also discuss key unanswered questions regarding mechanism, specificity, endosomal escape, and in vivo performance. Finally, we discuss illustrative examples and emerging translational applications of MTPs in intracellular drug delivery and molecular therapeutics. Together, these perspectives underscore the dual importance of MTPs as probes for fundamental biophysical studies of cell membranes and as promising tools to expand the universe of druggable intracellular targets.